BNL Acquisition: Celerion, Inc.

Broadstone Net Lease has acquired two properties tenanted by Celerion, Inc., one of the world’s largest clinical research organizations. Celerion conducts comprehensive clinical pharmacology studies, and focuses on complex trials for first-in-human and proof-to-concept studies that support innovative drug development. The two properties are located in Arizona and Nebraska, and were acquired via a sale-leaseback transaction.

  • Closing Date: June 24, 2015
  • Square Footage: 233,565
  • Lease Type: Triple-net
  • Lease Length:  15 Years
  • Rent Increases: 2.00% Annually
  • Broker/source: Andrew Sandquist, CBRE

Note: The brand listed may not represent BNL’s actual tenant but a lease guarantor, tenant franchise or a D/B/A (doing business as).